Evidence map›Paper›PMID 39927857›Full record

ArticleBriefings in bioinformatics2024

B-Lightning: using bait genes for marker gene hunting in single-cell data with complex heterogeneity.

Yiren Shao, Qi Gao, Liuyang Wang, Dongmei Li, Andrew B Nixon, Cliburn Chan, Qi-Jing Li, Jichun Xie

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Yiren ShaoDepartment of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, United States.
Qi GaoDepartment of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48104, United States.
Liuyang WangDepartment of Molecular Genetics and Microbiology, Duke University, Durham, NC 27708, United States.
Dongmei LiDepartment of Clinical and Translational Research, Unversity of Rochester Medical Center, Rochester, NY 14642, United States.
Andrew B NixonDepartment of Medicine, Duke University, Durham, NC 27708, United States.
Cliburn ChanDepartment of Biostatistics and Bioinformatics, Duke University, Durham, NC 27708, United States.
Qi-Jing LiInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research, 138673, Singapore.
Jichun XieDepartment of Biostatistics and Bioinformatics, Duke University, Durham, NC 27708, United States.

Funding

TriState SenNET (Lung and Heart) Tissue Map and Atlas consortiumU54AG075931 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI TOREN FINKEL, Melanie Koenigshoff · 2021 to 2026
$14.0M
The Duke Senescent Cell Evaluations in Normal Tissues (SCENT) Mapping CenterU54AG075936 · NIA · DUKE UNIVERSITY · PI LEE, PATTY J · 2021 to 2025
$12.7M
New computational methods to dynamically pinpointing the subregions carrying disease-associated rare variantsR01HG012555 · NHGRI · DUKE UNIVERSITY · PI XIE, JICHUN · 2022 to 2025
$1.6M
Exosomal epigenetic biomarkers associated with flavored electronic cigarette usein adultsR21ES032159 · NIEHS · UNIVERSITY OF ROCHESTER · PI LI, DONGMEI, RAHMAN, IRFAN · 2021 to 2022
$424k
National Instite on Aging 1U54AG075936NHGRI NIH HHS NIH 1R01HG012555NHGRI NIH HHS R01 HG012555NIA NIH HHS 1U54AG075936NIA NIH HHS NIH 1U54AG075931NIA NIH HHS U54 AG075931NIA NIH HHS U54 AG075936NIEHS NIH HHS NIH 1R21ES032159NIEHS NIH HHS R21 ES032159NIH
6 · The paper itself

Abstract

In single-cell studies, cells can be characterized with multiple sources of heterogeneity (SOH) such as cell type, developmental stage, cell cycle phase, activation state, and so on. In some studies, many nuisance SOH are of no interest, but may confound the identification of the SOH of interest, and thus affect the accurate annotate the corresponding cell subpopulations. In this paper, we develop B-Lightning, a novel and robust method designed to identify marker genes and cell subpopulations corresponding to an SOH (e.g. cell activation status), isolating it from other SOH (e.g. cell type, cell cycle phase). B-Lightning uses an iterative approach to enrich a small set of trustworthy marker genes to more reliable marker genes and boost the signals of the SOH of interest. Multiple numerical and experimental studies showed that B-Lightning outperforms existing methods in terms of sensitivity and robustness in identifying marker genes. Moreover, it increases the power to differentiate cell subpopulations of interest from other heterogeneous cohorts. B-Lightning successfully identified new senescence markers in ciliated cells from human idiopathic pulmonary fibrosis lung tissues, new T-cell memory and effector markers in the context of SARS-COV-2 infections, and their synchronized patterns that were previously neglected, new AD markers that can better differentiate AD severity, and new dendritic cell functioning markers with differential transcriptomics profiles across breast cancer subtypes. This paper highlights B-Lightning's potential as a powerful tool for single-cell data analysis, particularly in complex data sets where SOH of interest are entangled with numerous nuisance factors.

Indexed as

Single-Cell AnalysisCOVID-19Genetic MarkersHumansSARS-CoV-2Genetic Markersmarker gene identificationmulti-source heterogeneitysingle-cell RNA sequencing

Identifiers

PMID39927857
PMCPMC11808808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.